Search clinical trials for: Tamoxifen,
Total 398 results
-
Northwestern UniversityNational Cancer Institute (NCI); BHR Pharma, LLCRecruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage 0 Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | HER2/Neu Negative | PostmenopausalUnited States
-
Oregon Health and Science UniversityMerck Women's Health Investigator Initiated Studies ProgramCompletedBleeding | Breakthrough Bleeding | ImplantsUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Carcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus Cancer | Stage IIIC1 Uterine Corpus Cancer | Stage IIIC2 Uterine Corpus CancerUnited States
-
Institut Cancerologie de l'OuestActive, not recruiting
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedEstrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
European Institute of OncologyIstituto Oncologico Veneto IRCCS; Ente Ospedaliero Ospedali Galliera; Istituto...Not yet recruitingDuctal Carcinoma in Situ | RAD51C Gene Mutation | RAD51D Gene Mutation | PALB2 Gene Mutation | Lobular Carcinoma in Situ | ATM Gene Mutation | CDH1 Gene Mutation | CHEK2 Gene Mutation | BRCA MutationItaly
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast CancerUnited States, Canada, Peru
-
National Cancer Center, KoreaUnknown
-
The Methodist Hospital Research InstituteMillennium Pharmaceuticals, Inc.CompletedEstrogen Receptor Positive Breast CancerUnited States
-
Kafrelsheikh UniversityNot yet recruiting
-
TYK Medicines, IncRecruiting
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompleted
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension
-
Shaanxi Buchang Pharmaceutical Co., LtdUnknownAngina, StableChina
-
Sohag UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
Samsung Medical CenterUnknownBreast Cancer | Sleep DisorderKorea, Republic of
-
Bader, Ted, M.D.CompletedChronic Hepatitis CUnited States
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedEnd Stage Renal DiseaseUnited States
-
Institut Cancerologie de l'OuestCompletedNon Metastatic Breast CancerFrance
-
Yonsei UniversityInje UniversityCompletedBreast Neoplasms | Antineoplastic Agents | Therapeutic Uses | Survival AnalysisKorea, Republic of
-
Nalagenetics Pte LtdCompleted
-
University of NebraskaNot yet recruitingPancreatic Cyst | Pancreatic Mucinous Cystic NeoplasmUnited States
-
Assiut UniversityUnknown
-
National Cancer Institute (NCI)CompletedNeoplasm Metastasis | OsteosarcomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Sun Yat-sen UniversityNot yet recruiting
-
Eli Lilly and CompanyCompletedBreast NeoplasmsUnited States, Argentina, Chile, India, Mexico
-
Sun Yat-sen UniversityCompletedBreast Cancer MetastaticChina
-
Zhejiang Cancer HospitalCompletedUltrasonography | Lipemia | Endometrium | Mammography | EstrogenChina
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompleted
-
Karolinska University HospitalActive, not recruitingBreast Cancer | Breast Tumors | Breast Carcinoma | Cancer of Breast | Malignant Neoplasm of BreastSweden
-
Incyte CorporationTerminatedOvarian Cancer | Genitourinary (GU) TumorsUkraine, United Kingdom, United States, Australia, Canada, Russian Federation
-
National Institute of General Medical Sciences...Indiana University School of MedicineCompleted
-
University of NottinghamUnknown
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Recurrent Breast Cancer
-
Fengxi SuUnknownBreast Cancer Patients in Premenopausal | Estrogen and/or Progesterone Receptor PositiveChina
-
Radboud University Medical CenterCompleted
-
Oregon Health and Science UniversityCompletedMetrorrhagia | Menorrhagia | Medicated Intrauterine DevicesUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)TerminatedBreast CancerUnited States